Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro

American Journal of Pathology

Volumn 184, Issue 8, 2014, Pages 2275-2284

  Duan, Wen Juan ^a   Yu, Xueqing ^a   Huang, Xiao Ru ^b   Yu, Jian Wen ^b   Lan, Hui Yao ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CYTOKERATIN 18; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESOTHELIUM CELL; MOUSE; NONHUMAN; PERITONEAL BIOPSY; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ADVERSE EFFECTS; ANIMAL; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEAL FIBROSIS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84904668928     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.014     Document Type: Article

References (32)

1. P.J. Margetts, and D.N. Churchill Acquired ultrafiltration dysfunction in peritoneal dialysis patients J Am Soc Nephrol 13 2002 2787 2794
2. J.D. Williams, K.J. Craig, N. Topley, C. Von Ruhland, M. Fallon, G.R. Newman, R.K. Mackenzie, G.T. Williams Peritoneal Biopsy Study Group Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 13 2002 470 479
3. O. Devuyst, P.J. Margetts, and N. Topley The pathophysiology of the peritoneal membrane J Am Soc Nephrol 21 2010 1077 1085
4. T. Shimaoka, C. Hamada, K. Kaneko, H. Io, Y. Sekiguchi, S. Aruga, J. Inuma, Y. Inami, Y. Hotta, S. Horikoshi, T. Kumasaka, and Y. Tomino Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patients Nephrol Dial Transplant 25 2010 3379 3385
5. Y. Tomino Mechanisms and interventions in peritoneal fibrosis Clin Exp Nephrol 16 2012 109 114
6. P.J. Margetts, K.H. Oh, and M. Kolb Transforming growth factor-beta: importance in long-term peritoneal membrane changes Perit Dial Int 25 Suppl 3 2005 S15 S17
7. N.C. Mlambo, B. Hylander, and A. Brauner Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis Inflammation 23 1999 131 139
8. K.N. Lai, K.B. Lai, C.W. Lam, T.M. Chan, F.K. Li, and J.C. Leung Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis Am J Kidney Dis 35 2000 644 652
9. Q. Yao, K. Pawlaczyk, E.R. Ayala, A. Styszynski, A. Breborowicz, O. Heimburger, J.Q. Qian, P. Stenvinkel, B. Lindholm, and J. Axelsson The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions Nephron Exp Nephrol 109 2008 e71 e78
10. P.J. Margetts, M. Kolb, T. Galt, C.M. Hoff, T.R. Shockley, and J. Gauldie Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function J Am Soc Nephrol 12 2001 2029 2039
11. J.P. Rougier, S. Guia, J. Hagege, C.M. Hoff, T.R. Shockley, and J. Gauldie PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-β1 Kidney Int 54 1998 87 98
12. M. Yáñez-Mó, E. Lara-Pezzi, R. Selgas, R. Selgas, M. Ramírez-Huesca, C. Domínguez-Jiménez, J.A. Jiménez-Heffernan, A. Aguilera, J.A. Sánchez-Tomero, M.A. Bajo, V. Alvarez, M.A. Castro, G. del Peso, A. Cirujeda, C. Gamallo, F. Sánchez-Madrid, and M. López-Cabrera Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells N Engl J Med 348 2003 403 413
13. A.H. Yang, J.Y. Chen, and J.K. Lin Myofibroblastic conversion of mesothelial cells Kidney Int 63 2003 1530 1539
14. H.Y. Lan Diverse roles of TGF-β/Smads in renal fibrosis and inflammation Int J Biol Sci 7 2011 1056 1067
15. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.M. Gauthier Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene EMBO J 17 1998 3091 3100
16. P. Patel, Y. Sekiguchi, K.H. Oh, S.E. Patterson, M.R. Kolb, and P.J. Margetts Smad3-dependent and -independent pathways are involved in peritoneal membrane injury Kidney Int 77 2010 319 328
17. J. Nie, X. Dou, W. Hao, X. Wang, W. Peng, Z. Jia, W. Chen, X. Li, N. Luo, H.Y. Lan, and X.Q. Yu Smad7 gene transfer inhibits peritoneal fibrosis Kidney Int 72 2007 1336 1344
18. H. Guo, J.C. Leung, M.F. Lam, L.Y. Chan, A.W. Tsang, H.Y. Lan, and K.N. Lai Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis J Am Soc Nephrol 18 2007 2689 2703
19. X.M. Meng, X.R. Huang, A.C. Chung, W. Qin, X. Shao, P. Igarashi, W. Ju, E.P. Bottinger, and H.Y. Lan Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis J Am Soc Nephrol 21 2010 1477 1487
20. Q. Zhou, M. Yang, H. Lan, and X. Yu miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai Am J Pathol 183 2013 808 819
21. W. Ju, A. Ogawa, J. Heyer, D. Nierhof, L. Yu, R. Kucherlapati, D.A. Shafritz, and E.P. Bottinger Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation Mol Cell Biol 26 2006 654 667
22. X. Yang, J.J. Letterio, R.J. Lechleider, L. Chen, R. Hayman, H. Gu, A.B. Roberts, and C. Deng Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta EMBO J 18 1999 1280 1291
23. A.C. Chung, H. Zhang, Y.Z. Kong, J.J. Tan, X.R. Huang, J.B. Kopp, and H.Y. Lan Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling J Am Soc Nephrol 21 2010 249 260
24. X.M. Meng, X.R. Huang, J. Xiao, A.C. Chung, W. Qin, H.Y. Chen, and H.Y. Lan Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro Kidney Int 81 2012 266 279
25. M. Nomura, and E. Li Smad2 role in mesoderm formation, left-right patterning and craniofacial development Nature 393 1998 786 790
26. T.M. Chan, J.K. Leung, R.C. Tsang, Z.H. Liu, L.S. Li, and S. Yung Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells Kidney Int 64 2003 519 533
27. K. Kurata, S. Maruyama, S. Kato, W. Sato, J. Yamamoto, T. Ozaki, A. Nitta, T. Nabeshima, Y. Morita, M. Mizuno, Y. Ito, Y. Yuzawa, and S. Matsuo Tissue-type plasminogen activator deficiency attenuates peritoneal fibrosis in mice Am J Physiol Renal Physiol 297 2009 F1510 F1517
28. J. Loureiro, A. Aguilera, R. Selgas, P. Sandoval, P. Albar- Vizcaíno, M.L. Pérez-Lozano, V. Ruiz-Carpio, P.L. Majano, S. Lamas, F. Rodríguez-Pascual, F. Borras-Cuesta, J. Dotor, and M. López-Cabrera Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage J Am Soc Nephrol 22 2011 1682 1695
29. Q. Liu, H. Mao, J. Nie, W. Chen, Q. Yang, X. Dong, and X. Yu Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells Perit Dial Int 28 Suppl 3 2008 S88 S95
30. K.A. Brown, J.A. Pietenpol, and H.L. Moses A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling J Cell Biochem 101 2007 9 33
31. P. ten Dijke, and C.S. Hill New insights into TGF-beta-Smad signalling Trends Biochem Sci 29 2004 265 273
32. Z.D. Lv, H.B. Wang, F.N. Li, L. Wu, C. Liu, G. Nie, B. Kong, H.L. Qu, and J.G. Li TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis Int J Mol Med 29 2012 373 379